Additional alterations to the insulin signaling pathway in AD patients involve changes in the distribution patterns and morphology of insulin receptors [87], IGF-1 receptor insensitivity, and basal elevation in IRS-1 phosphorylation [88]. The gene discussed is INSR; the disease is Alzheimer disease.